Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 30
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Indian J Otolaryngol Head Neck Surg ; 75(3): 2155-2162, 2023 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-37636719

RESUMEN

To determine the prevalence of anatomical variations of nasal cavity and paranasal sinuses of patients with chronic rhinosinusitis (CRS) on CT scan imaging. To correlate the Anatomical variations with the extent of CRS. 100 patients attending the ENT outpatient department with clinically diagnosed CRS were selected for study based on inclusion and exclusion criteria. Patients were subjected to CT scan and diagnostic nasal endoscopy. The correlation of anatomical variation with severity of CRS based on radiological score and endoscopic score was observed. Deviated nasal septum was the most common anatomical variation observed in 71% cases. Followed by Agger nasi (68%), concha bullosa (55%), Onodi cell (25%), Haller cell (14%), frontal sinus hypoplasia (2%) and uncinate bulla (1%) respectively. Statistically significant relationship of radiological score with left side Bullous Concha Bullosa and highly statistically significant relationship with Haller Cell was observed. While statistically significant relationship between Deviated Nasal Septum on left side with endoscopic score was also observed. Correlation of anatomical variation with CRS concludes on the note that some variations cause impaired sinus drainage and ventilation leading to recurrent sinusitis. Also, incidence of these variations was comparable to other studies done in asymptomatic population therefore, simply detection of a solitary anatomical variant itself does not determine predisposition to disease or the pathogenesis of the CRS and that we should have a critical look out for these anatomical variations from point of view of surgical management.

2.
PLoS One ; 16(7): e0254781, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-34297746

RESUMEN

INTRODUCTION: Improving quality of care (QoC) for childbirth and sick newborns is critical for maternal and neonatal mortality reduction. Information on the process and impact of quality improvement at district and sub-district hospitals in India is limited. This implementation research was prioritized by the Haryana State (India) to improve the QoC for maternal and newborn care at the busy hospitals in districts. METHODS: This study at nine district and sub-district referral hospitals in three districts (Faridabad, Rewari and Jhajjar) during April 2017-March 2019 adopted pre-post, quasi-experimental study design and plan-do-study-act quality improvement method. During the six quarterly plan-do-study-act cycles, the facility and district quality improvement teams led the gap identification, solution planning and implementation with external facilitation. The external facilitators monitored and collected data on indicators related to maternal and newborn service availability, patient satisfaction, case record quality, provider's knowledge and skills during the cycles. These indicators were compared between baseline (pre-intervention) and endline (post-intervention) cycles for documenting impact. RESULTS: The interventions closed 50% of gaps identified, increased the number of deliveries (1562 to 1631 monthly), improved care of pregnant women in labour with hypertension (1.2% to 3.9%, p<0.01) and essential newborn care services at birth (achieved ≥90% at most facilities). Antenatal identification of high-risk pregnancies increased from 4.1% to 8.8% (p<0.01). Hand hygiene practices improved from 35.7% to 58.7% (p<0.01). The case record completeness improved from 66% to 87% (p<0.01). The time spent in antenatal clinics declined by 19-42 minutes (p<0.01). The pooled patient satisfaction scores improved from 82.5% to 95.5% (p<0.01). Key challenges included manpower shortage, staff transfers, leadership change and limited orientation for QoC. CONCLUSION: This multipronged quality improvement strategy improved the maternal and newborn services, case documentation and patient satisfaction at district and sub-district hospitals. The processes and lessons learned shall be useful for replicating and scaling up.


Asunto(s)
Implementación de Plan de Salud/métodos , Hospitales Públicos/normas , Servicios de Salud Materna/normas , Calidad de la Atención de Salud , Adulto , Femenino , Humanos , India , Recién Nacido , Masculino , Satisfacción del Paciente
3.
Indian J Clin Biochem ; 30(1): 72-7, 2015 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-25646044

RESUMEN

The antidyslipidemic activity of Ocimum sanctum leaf extract was studied in streptozotocin induced diabetic rats. In this model, there was significant increase in plasma markers of diabetic-dyslipidemia following diminution of lipid metabolizing enzymes. Oral administration of leaf extract (500 mg/kg b.w.p.o.) for 15 days resulted in significant decrease in diabetogenic and dyslipidemia parameters; namely blood glucose, glycosylated hemoglobin, lipid peroxide, free fatty acids, small dense low density lipoprotein, lipid and protein components of plasma lipoproteins, adipose and liver. The regulation of lipids was accompanied by stimulation of postheparin lipolytic activity, reactivation of lecithin cholesterol acyl transferase and hepatic lipoprotein lipase enzymes. The results of the present study demonstrated antidyslipidemic and antioxidant activities in leaf extract of O. sanctum which could be used in prevention of diabetic-dyslipidemia and related complications.

4.
Indian J Clin Biochem ; 30(1): 78-83, 2015 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-25646045

RESUMEN

The hypolipidemic activity of Cassia tora (Chakvat, Chakunda) (Family: Caesalpiniaceae) seeds extract have been studied in two models of hyperlipidemia in rats. In an acute model, hyperlipidemia was induced by injecting a single dose of Triton WR-1339 (400 mg/kg, b.w.) intraperitonially in rats. Feeding with C. tora seed extract at the dose of 500 mg/kg, b.w. exerted significant lipid lowering effect as assessed by the reversal of plasma levels of total cholesterol, phospholipids, triglyceride and reactivation of post heparin lipolytic activity. In the chronic model, hyperlipidemia was induced by feeding with cholesterol rich-HFD in rats. The treatment with seeds extract of C. tora (500 mg/kg, b.w.) simultaneously for 15 days also caused lowering of lipid levels in plasma and liver following reactivation of plasma post heparin lipolytic activity and hepatic lipoprotein lipase activity in animals. The hypolipidemic activity of C. tora seeds was compared with a standard drug guggulipid (200 mg/kg, b.w.) in both models.

5.
Appl Radiat Isot ; 86: 97-101, 2014 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-24530977

RESUMEN

Potential of aqueous solutions of cyanocobalamin in gamma radiation dosimetry was investigated. The solutions are inexpensive, nontoxic and easy-to-prepare dosimeters, which could be useful for measuring gamma radiation doses in various applications, such as quarantine treatment of fruit or insect disinfestation of grains and pulses. The optical absorbance of cyanocobalamin solutions of the optimal concentration 0.08 mM decreases with increasing radiation dose. The reproducible dependence of the absorbance decrease on the dose can be described with a polynomial. Pre- and post-irradiation stability of the solution absorbance, as well as effects of the irradiation temperature and dose rate, were studied. The response is not significantly affected by storage of the irradiated dosimeters under ambient conditions for 20 days. The performance characteristics of this chemical dosimetry system suggest that it can be useful to measure doses in irradiations of food.


Asunto(s)
Radioisótopos de Cobalto , Irradiación de Alimentos , Radiometría/métodos , Vitamina B 12/efectos de la radiación , Relación Dosis-Respuesta en la Radiación , Irradiación de Alimentos/métodos , Rayos gamma , Reproducibilidad de los Resultados , Soluciones , Análisis Espectral
6.
Indian J Tuberc ; 61(4): 318-24, 2014 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-25675695

RESUMEN

OBJECTIVE: The aim of the study was to elucidate the profile of adverse drug reactions (ADRs) associated with second-line anti-tubercular treatment for drug-resistant tuberculosis. MATERIAL AND METHODS: ADR profile of diagnosed drug-resistant tuberculosis cases on supervised second-line anti-tubercular drug regimen under Programmatic Management of Drug-resistant Tuberculosis under Revised National Tuberculosis Control Programme, were studied over two years' period. Adverse reactions were categorised into mild, moderate and severe types with subsequent systematic data-analysis. RESULTS: Out of total 207 patients in the study, 81.16% reported with adverse drug reactions. Out of total 195 adverse events, 63.58%, 18.46% and 17.94% were of mild, moderate and severe types respectively. Gastrointestinal events, hepatitis, hearing impairment, arthralgia, psychosis, hypothyroidism, visual disturbances, giddiness, peripheral neuropathy, skin reactions, swelling or pain at injection site, anorexia and sleep disturbances were important amongst these. High proportion of drug and/or alcohol abuse was an important observation. The offending drug(s) had to be terminated in 12.08% of the patients. CONCLUSION: Early detection, management and pharmaco-vigilance reporting of ADRs remain key factors in the management of drug-resistant tuberculosis with remarkable relevance of the need for early diagnosis and treatment of 'drug-sensitive tuberculosis', to prevent emergence of drug-resistant tuberculosis.


Asunto(s)
Antituberculosos/efectos adversos , Tuberculosis Resistente a Múltiples Medicamentos/tratamiento farmacológico , Tuberculosis Pulmonar/tratamiento farmacológico , Adolescente , Adulto , Anciano , Artralgia/inducido químicamente , Ataxia/inducido químicamente , Enfermedad Hepática Inducida por Sustancias y Drogas/etiología , Niño , Cicloserina/efectos adversos , Erupciones por Medicamentos/etiología , Quimioterapia Combinada , Etambutol/efectos adversos , Etionamida/efectos adversos , Femenino , Enfermedades Gastrointestinales/inducido químicamente , Pérdida Auditiva/inducido químicamente , Humanos , Hipotiroidismo/inducido químicamente , India , Kanamicina/efectos adversos , Levofloxacino/efectos adversos , Masculino , Persona de Mediana Edad , Enfermedades del Sistema Nervioso Periférico/inducido químicamente , Psicosis Inducidas por Sustancias/etiología , Pirazinamida/efectos adversos , Índice de Severidad de la Enfermedad , Trastornos de la Visión/inducido químicamente , Adulto Joven
7.
Indian J Clin Biochem ; 28(1): 46-50, 2013 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-24381420

RESUMEN

The antidyslipidemic activity of Hibiscus rosa sinensis (Malvaceae) root extract has been studied in alloxan induced diabetic rats. In this model, oral administration of root extract (500 mg/kg bw. p.o.) for 15 days resulted in significant decreased in the levels of blood glucose, plasma lipids and reactivated post heparin lipoprotein lipase activity in alloxan induced diabetic rats. Furthermore, the root extract (50-500 µg) when tested for its antioxidant activity, inhibited the generation of super oxide anions and hydroxyl radicals, in both enzymic and non enzymic systems in vitro. The results of the present study demonstrated antidyslipidemic and antioxidant activities in root extract of H. rosa sinensis which could be used in prevention of diabetic-dyslipidemia and related complications.

8.
Indian J Biochem Biophys ; 47(2): 104-9, 2010 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-20521624

RESUMEN

The present study was carried out to explore the anti-diabetic, anti-dyslipoproteinemic and anti-oxidant activities of Anthocephalus indicus root extract in alloxan-induced (150 mg/kg body wt.) diabetic rats. A marked increase in plasma levels of glucose and lipid peroxides accompanied with an elevation in the lipids and apoprotein levels of serum very low density lipoprotein (VLDL) and low density lipoprotein (LDL) following decrease in lipid and protein constituents of high density lipoprotein (HDL) were observed. The alterations in lipoprotein pattern was associated with inhibition of lipolytic and antioxidant enzymes. Oral administration of root extract (500 mg/kg body wt.) for 30 days in dyslipidemic animals resulted in significant decrease in plasma glucose, total cholesterol, phospholipids, triglyceride and lipid peroxides. The decrease of lipids and apoprotein levels of VLDL and LDL were followed by stimulation of plasma post-heparin lipolytic activity and lecithin cholesterol acyltransferase as well as hepatic superoxide dismutase and catalase activities. Lipid and apoprotein levels of HDL were also recovered partially on treatment with root extract.


Asunto(s)
Antioxidantes/farmacología , Hipolipemiantes/farmacología , Extractos Vegetales/farmacología , Raíces de Plantas/química , Árboles/química , Animales , Antioxidantes/uso terapéutico , Ácidos y Sales Biliares/metabolismo , Diabetes Mellitus Experimental/sangre , Diabetes Mellitus Experimental/tratamiento farmacológico , Diabetes Mellitus Experimental/metabolismo , Ácidos Grasos/sangre , Ácidos Grasos/metabolismo , Heces , Hipolipemiantes/uso terapéutico , Metabolismo de los Lípidos/efectos de los fármacos , Peróxidos Lipídicos/sangre , Hígado/efectos de los fármacos , Hígado/enzimología , Hígado/metabolismo , Masculino , Ratas
9.
Evid Based Complement Alternat Med ; 7(3): 317-22, 2010 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-18955320

RESUMEN

The lipid lowering activity of Anthocephalus indicus (family Rubiaceae; Hindi name Kadamba) root extract has been studied in triton WR-1339 induced hyperlipidemia in rats. In this model, feeding with root extract (500 mg kg(-1) b.w.) lowered plasma lipids and reactivated post-heparin lipolytic activity in hyperlipidemic rats. Furthermore, the root extract (50-500 µM) inhibited the generation of superoxide anions and hydroxyl radicals, in both enzymic and non-enzymic systems, in vitro. The results of the present study demonstrated both lipid lowering and antioxidant activities in root extract of A. indicus, which could help prevention of hyperlipidemia and related diseases.

10.
Brain Res ; 1253: 107-16, 2009 Feb 09.
Artículo en Inglés | MEDLINE | ID: mdl-19073157

RESUMEN

Aluminum exposure is known to be associated with oxidative stress and cognitive decline in experimental animals but the precise mechanism of its neurotoxicity has not yet been delineated. The present study attempts to assess the learning and memory capacity of rats using Y-maze test for cognitive functioning. The markers of oxidative stress, e.g. lipid peroxides and endogenous antioxidants as well as metals (Al, Fe, Cu, Zn and Se) were measured in the brain frontal cortex of young and aged rats fed with AlCl(3) (100 mg/kg b.w.) for 90 days and normal saline treated controls. We observed significant changes between young and aged Al treated rats and their controls in terms of lipid peroxides and endogenous antioxidants. Lipofuscin content was significantly increased in Al treated aged rats along with higher concentration of Al, Fe and Zn with concomitantly low levels of Cu, and Se. Ultrastructural studies of the frontal cortex of exposed rats revealed that the changes were more pronounced in the aged treated rats in terms of presence of spongiform lipofuscin, vacuolization and lysosomal degradation. Changes in synaptic morphology and decreased number of synapses were detected in the frontal cortex of Al treated aged rats. On the basis of the results of the present study, we conclude that Al may be linked with neurolipofuscinogenesis and alteration in neurobehavioral activity and these changes may be responsible for the development of age related disorders, such as Alzheimer's disease.


Asunto(s)
Envejecimiento , Compuestos de Aluminio/toxicidad , Cloruros/toxicidad , Lóbulo Frontal/efectos de los fármacos , Peroxidación de Lípido/efectos de los fármacos , Lipofuscina/metabolismo , Neuronas/efectos de los fármacos , Cloruro de Aluminio , Animales , Antioxidantes/metabolismo , Conducta Animal/efectos de los fármacos , Lóbulo Frontal/metabolismo , Lóbulo Frontal/ultraestructura , Peróxidos Lipídicos/metabolismo , Masculino , Aprendizaje por Laberinto/efectos de los fármacos , Metales Pesados/metabolismo , Neuronas/metabolismo , Tamaño de los Órganos , Ratas , Ratas Wistar , Selenio/metabolismo , Sinapsis/efectos de los fármacos
11.
Indian J Biochem Biophys ; 46(6): 507-10, 2009 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-20361715

RESUMEN

The hypolipidemic activity of Hibiscus rosa sinensis (family Malvaceae) root extract was studied on triton and cholesterol-rich high fat diet (HFD) induced models of hyperlipidemia in rats. In triton WR-1339-induced hyperlipidemia, feeding with root extract (500 mg/kg body wt/day p.o.) exerted lipid-lowering effect, as assessed by reversal of plasma levels of total cholesterol (TC), phospholipids (PL) and triglycerides (TG) and reactivation of post-heparin lipolytic activity (PHLA) of plasma. The other model was fed with cholesterol-rich HFD and root extract (500 mg/kg body wt/ day p.o.) simultaneously for 30 days. This also caused lowering of lipid levels in plasma and liver homogenate and reactivation of plasma PHLA and hepatic total lipoprotein lipase activity. The hypolipidemic activity of Hibiscus rosa sinensis root was compared with a standard drug guggulipid (200 mg/kg body wt/day p.o.), a known lipid- lowering agent in both models. Histopathological findings in rat liver supported the protective role of H. rosa sinensis root extract in preventing cholesterol-rich HFD-induced hepatic steatosis.


Asunto(s)
Hibiscus/química , Hipolipemiantes/farmacología , Extractos Vegetales/farmacología , Raíces de Plantas/química , Animales , Colesterol/metabolismo , Grasas de la Dieta/efectos adversos , Hiperlipidemias/inducido químicamente , Hiperlipidemias/metabolismo , Hiperlipidemias/patología , Hígado/efectos de los fármacos , Hígado/patología , Masculino , Fitoterapia , Polietilenglicoles/farmacología , Ratas
12.
Indian J Clin Biochem ; 24(1): 65-9, 2009 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-23105809

RESUMEN

The present study was carried out to evaluate the hypoglycemic, lipid lowering and antioxidant activities in root extract of Anthocephalus indicus (A indicus) in alloxan inducd diabetic rats. Oral administration of ethanol extract of root (500mg/ kg body weight) for 21 days resulted in significant decrease in the levels of blood glucose, triglycerides, total cholesterol, phospholipid and free fatty acids. Furthermore, the root extract (100-400µg) inhibited the generation of superoxide anions and hydroxyl radicals, in both enzymic and non-enzymic systems, in vitro. The result of the present study demonstrated hypoglycemic, lipid lowering and antioxidant activities in root extract of A indicus, which could help in prevention of diabetic dyslipidemia and related diseases.

13.
J Med Food ; 11(3): 506-12, 2008 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-18800899

RESUMEN

In the present investigation we report the protective potential of some herbal hypoglycemic agents on antioxidant status and levels of metal ions in streptozotocin-induced diabetic rats. Furthermore, in vitro antioxidant activity of the herbs was also evaluated. Induction of diabetes mellitus in rats caused an increase in blood lipid peroxide levels that was associated with the reduced activity of red blood cell (RBC) antioxidant enzymes--namely, superoxide dismutase, catalase, glutathione reductase, and glutathione peroxidase--along with depletion of plasma reduced glutathione (GSH) and copper, zinc, iron, magnesium, and selenium levels. Oral treatment of diabetic rats with Allium sativum, Azadirachta indica, Momordica charantia, and Ocimum sanctum extracts (500 mg/kg of body weight) not only lowered the blood glucose level but also inhibited the formation of lipid peroxides, reactivated the antioxidant enzymes, and restored levels of GSH and metals in the above-mentioned model. The herbal extracts (50-500 microg) inhibited the generation of superoxide anions (O(2)(-.)) in both enzymatic and nonenzymatic in vitro systems. These preparations also inhibited the ferrous-sodium ascorbate-induced formation of lipid peroxides in RBCs. The in vivo and in vitro protective effects of the above-mentioned herbal drugs were also compared with that of glibenclamide. On the basis of our results, we conclude that the above-mentioned herbal plants not only possess hypoglycemic properties, but they also decrease oxidative load in diabetes mellitus. Therefore, we propose that long-term use of such agents might help in the prevention of diabetes-associated complications. However, the extrapolation of these results to humans needs further in-depth study.


Asunto(s)
Antioxidantes/metabolismo , Diabetes Mellitus Experimental/tratamiento farmacológico , Hipoglucemiantes/farmacología , Fitoterapia , Animales , Antioxidantes/farmacología , Glucemia/efectos de los fármacos , Diabetes Mellitus Experimental/sangre , Diabetes Mellitus Experimental/metabolismo , Glutatión/sangre , Hipoglucemiantes/uso terapéutico , India , Peroxidación de Lípido/efectos de los fármacos , Masculino , Estrés Oxidativo/efectos de los fármacos , Plantas Medicinales , Ratas , Oligoelementos/metabolismo , Xantina/metabolismo
14.
Cancer Chemother Pharmacol ; 61(3): 355-63, 2008 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-17429627

RESUMEN

PURPOSE: To investigate the mechanism of cell death induced by the N-alkylated prodigiosin analogue, 2,2'-[3-methoxy-1'amyl-5'-methyl-4-(1''-pyrryl)] dipyrryl-methene (MAMPDM) in S-180 and EL-4 tumour cell lines. METHODS: Effect of MAMPDM on cell viability was assessed by MTT dye conversion. Induction of apoptosis was assessed by monitoring caspase 3 activity using a fluorogenic substrate, fragmentation of DNA by gel electrophoresis and sub-diploid DNA containing cells by flowcytometry. Necrosis was estimated by flowcytometric analysis of the uptake of propidium iodide. RESULTS: MAMPDM inhibited the proliferation of murine fibrosarcoma, S-180 cells and induced cell death. Investigations into the mechanism of cell death by MAMPDM in S-180 cells showed absence of hallmarks of apoptotic cell death such as activation of caspase 3, DNA fragmentation and presence of cells with sub-diploid DNA content. However, there was a rapid loss of membrane integrity as assessed by uptake of propidium iodide, which is characteristic of necrosis. In contrast to induction of necrosis in S-180 cells, MAMPDM induced apoptotic cell death in EL-4 cells as evident by activation of caspase 3, fragmentation of DNA and sub-diploid DNA containing cells. CONCLUSIONS: MAMPDM could induce cell death by either apoptosis or necrosis depending upon the cell type. This would be of advantage in elimination of tumor cells defective in apoptotic pathway and therefore, refractory to the conventional therapies.


Asunto(s)
Alquenos/farmacología , Antineoplásicos/farmacología , Apoptosis/efectos de los fármacos , Prodigiosina/análogos & derivados , Prodigiosina/farmacología , Pirroles/farmacología , Alquilación , Animales , Línea Celular Tumoral , Permeabilidad de la Membrana Celular/efectos de los fármacos , Supervivencia Celular/efectos de los fármacos , Fragmentación del ADN/efectos de los fármacos , ADN de Neoplasias/biosíntesis , ADN de Neoplasias/genética , Dactinomicina/farmacología , Diploidia , Inhibidores Enzimáticos/farmacología , Linfoma de Células T/tratamiento farmacológico , Linfoma de Células T/patología , Ratones , Necrosis , Ratas , Sarcoma 180/tratamiento farmacológico , Estaurosporina/farmacología , Sales de Tetrazolio , Tiazoles
15.
Bioorg Med Chem ; 16(5): 2489-98, 2008 Mar 01.
Artículo en Inglés | MEDLINE | ID: mdl-18083521

RESUMEN

omega-(2-Naphthyloxy) amino alkanes, obtained as major by-product during course of synthesis of carbamate esters from omega-(2-naphthyloxy) alkyl halides and amines, showed significant anti-hyperglycemic and lipid lowering activities in various test models as a novel class of compounds. Compounds were tested in rat GLM, SLM, STZ, and STZ-S models at 100mg/kg dose. Of these compound 13 was found to be the most active which caused lowering of sugar by 33.6%, 31.0%, 28.5%, and 73.8% in GLM, SLM, STZ, STZ-S, and db/db mice models, respectively. It also significantly effected lowering of LDL in rat model and also in Hamster model without reducing HDL. Most of the compounds showing anti-diabetic and lipid lowering activity have shown promising PPAR-alpha/gamma/delta-activity. Compounds 6, 13, and 19 have shown very good PPAR-alpha/gamma/delta activity.


Asunto(s)
Alcanos/síntesis química , Alcanos/farmacología , Hipoglucemiantes/síntesis química , Hipoglucemiantes/farmacología , Hipolipemiantes/síntesis química , Hipolipemiantes/farmacología , Naftalenos/química , Alcanos/química , Alcanos/clasificación , Alquilación , Aminación , Animales , Hipoglucemiantes/química , Hipoglucemiantes/clasificación , Hipolipemiantes/química , Hipolipemiantes/clasificación , Metabolismo de los Lípidos/efectos de los fármacos , Masculino , Estructura Molecular , PPAR gamma/metabolismo , Ratas , Relación Estructura-Actividad
16.
Int Immunopharmacol ; 7(13): 1695-703, 2007 Dec 15.
Artículo en Inglés | MEDLINE | ID: mdl-17996679

RESUMEN

Prodigiosins have emerged as a novel family of tripyrrole compounds with significant T cell specific immunosuppressive potential. We had previously reported the immunosuppressive activity of a novel N-alkylated prodigiosin analogue, 2,2'-[3-methoxy-1'amyl-5'-methyl-4-(1''-pyrryl)] dipyrryl-methene (MAMPDM) in mitogen stimulated spleen cells. There was an increase in the accumulation of IL-2 and induction of apoptotic cell death. Since IL-2 regulates both cellular proliferation and activation induced cell death (AICD), we have investigated the effect of MAMPDM on the expression of IL-2 regulated genes that are involved in these two opposite processes. The mitogen stimulated mouse spleen cells did not undergo a single division in presence of proliferation inhibitory concentrations of MAMPDM. An increase in the percentage of apoptotic cells was observed in the undivided cell population. The cells were arrested in G1 phase independent of the p53 expression. Expression of IL-2 regulated genes such as CD71, proliferating cell nuclear antigen (PCNA) and cyclin D was suppressed while that of Fas was not. Thus, in the presence of MAMPDM there was selective inhibition of only the pro-mitogenic signaling and not that of pro-apoptotic signaling by IL-2. The induction of apoptosis in presence of MAMPDM was the effect rather than cause for the anti-proliferative activity.


Asunto(s)
Alquenos/farmacología , Inmunosupresores/farmacología , Interleucina-2/fisiología , Prodigiosina/análogos & derivados , Pirroles/farmacología , Animales , Antígenos CD/análisis , Antígenos de Diferenciación de Linfocitos T/análisis , Apoptosis/efectos de los fármacos , División Celular/efectos de los fármacos , Ciclina D , Ciclinas/antagonistas & inhibidores , Relación Dosis-Respuesta a Droga , Femenino , Lectinas Tipo C , Masculino , Ratones , Prodigiosina/farmacología , Antígeno Nuclear de Célula en Proliferación/análisis , Receptores de Transferrina/antagonistas & inhibidores , Proteína p53 Supresora de Tumor/antagonistas & inhibidores , Receptor fas/biosíntesis
17.
Res Microbiol ; 158(5): 399-404, 2007 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-17467243

RESUMEN

A bacterial strain producing a novel prodigiosin analogue 2,2'-[3-methoxy-1'amyl-5'-methyl-4-(1''-pyrryl)] dipyrrylmethene (MAMPDM) possessing potent cytotoxic activity towards cancer cells was isolated and identified. The bacterial cells were spherical and occurred singly, and some of the biochemical tests matched with Micrococcus. Therefore, the isolate was earlier tentatively reported to be Micrococcus sp. In the present studies, analytical profile index (API) suggested this organism to be Klebsiella. However, Klebsiella is not known to produce the red pigment prodigiosin, which is produced by Serratia species and some other bacteria. Based on other biochemical characteristics, particularly DNase, gelatinase, lipase, ornithine decarboxylase, presence of a cell-associated N-alkylated prodigiosin (MAMPDM) and organic solvent tolerance, the strain has now been identified as a variant of Serratia marcescens. 16S rRNA gene analysis conclusively established this organism as S. marcescens ost3. The red pigment (MAMPDM) of this organism showed selective cytotoxic activity in cancer cell lines of different origin (LS-A and U937) and reduced toxicity to non-malignant cells. The LC50 of MAMPDM was 1.59 microM and 0.176 microM for U937 and LS-A cells, respectively, while there was no effect on the viability of L929, a non-malignant cell line, at these concentrations. Thus, S. marcescens ost3 may serve as a source of a new anti-cancer compound.


Asunto(s)
Alquenos/metabolismo , Antineoplásicos/metabolismo , Pirroles/metabolismo , Serratia marcescens/metabolismo , Alquenos/farmacología , Animales , Antineoplásicos/farmacología , Gatos , Línea Celular , Supervivencia Celular/efectos de los fármacos , ADN Bacteriano/química , ADN Bacteriano/genética , Humanos , Ratones , Datos de Secuencia Molecular , Filogenia , Pigmentos Biológicos/metabolismo , Pigmentos Biológicos/farmacología , Reacción en Cadena de la Polimerasa , Prodigiosina/análogos & derivados , Prodigiosina/farmacología , Pirroles/farmacología , ARN Ribosómico 16S/genética , Análisis de Secuencia de ADN , Serratia marcescens/genética , Serratia marcescens/aislamiento & purificación , Células U937
18.
Indian J Biochem Biophys ; 44(5): 295-302, 2007 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-18341204

RESUMEN

Prodigiosins (PrGs) are a family of promising therapeutic molecules, isolated mostly from Gram-negative bacteria and characterized by a common pyrryldipyrrylmethene structure with varying side chains. They show a broad spectrum of activities such as anti-microbial, anti-malarial, anti-cancer and immunosuppressive. PrGs are attracting increasing attention due to the ongoing research for less toxic, but effective agents for cancer chemotherapy and immunosuppression for preventing allograft rejection and autoimmunity. Different analogues have been synthesized and evaluated. This review discusses the immunosuppressive and anti-cancer activities of this class of compounds, as both involve inhibition of cell proliferation. The main focus is on the in vitro and in vivo immunosuppressive activity of the different PrGs and the mechanisms involved. PrGs primarily target the T cells, though some effects are observed on other cell types also. Unlike the well-known immunosuppressant cyclosporin A, PrGs do not inhibit the secretion of IL-2 but inhibit the mitogenic signaling from IL-2, suggesting a different mechanism of action. Janus tyrosine kinase 3 (Jak3) that associates with IL-2R upon activation is considered as the molecular target for PrGs. Its restricted expression makes Jak3 as an attractive target for immunosuppressive therapy. However, the available literature suggests that some other pathways are also influenced by the PrGs. These may be important for the anti-cancer activity, as well as immunosuppressive action. Therefore, PrGs appear to be potential candidates for pharmaceutical development as immunosuppressants and also as anti-cancer agents.


Asunto(s)
Inmunidad Innata/efectos de los fármacos , Modelos Inmunológicos , Neoplasias/tratamiento farmacológico , Neoplasias/inmunología , Prodigiosina/administración & dosificación , Prodigiosina/inmunología , Animales , Antineoplásicos/administración & dosificación , Antineoplásicos/inmunología , Humanos , Inmunidad Innata/inmunología , Inmunosupresores/administración & dosificación , Inmunosupresores/inmunología
19.
Biochim Biophys Acta ; 1770(1): 143-9, 2007 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-17113233

RESUMEN

In the presence of a nonlethal concentration of Cu(II), washed Escherichia coli ATCC8739 cells were killed by a novel tripyrrole 1, isolated as a red pigment from the Serratia sp. Cell killing was accompanied by a depletion in the potassium pools of the cells due to the damage to the cytoplasmic membrane, without any detectable DNA damage as revealed by the transformed plasmid DNA and phage induction assay. This revealed that the bactericidal activity of compound 1 in the presence of Cu(II) results from membrane damage. Induction of endogenous catalase in the E. coli cells increased their resistance against the combination of compound 1 and Cu(II). Although compound 1 alone generated large amount of reactive oxygen species (ROS), it did not show any cell killing against E. coli in the absence of Cu(II). The Cu(II)-dependent bactericidal activity of compound 1 was suppressed by ethylenediaminetetraacetate, bathocuproine, catalase and superoxide disumutase (SOD), but not by dimethyl sulfoxide. These findings suggest that recycling redox reactions between Cu(II) and Cu(I), involving compound 1 and hydrogen peroxide on the cell surface, must be important in the mechanism of the killing. Compound 1 alone showed selective bactericidal activity against the gram positive bacterium, Bacillus cereus ATCC 6630, possibly due to its differential cellular transport.


Asunto(s)
Cobre/toxicidad , Citoplasma/efectos de los fármacos , Pirroles/farmacología , Catalasa/metabolismo , Catalasa/farmacología , Daño del ADN , Dimetilsulfóxido/farmacología , Ácido Edético/farmacología , Escherichia coli/efectos de los fármacos , Escherichia coli/genética , Fenantrolinas/farmacología , Especies Reactivas de Oxígeno/metabolismo , Superóxido Dismutasa/farmacología
20.
Bioorg Med Chem Lett ; 16(23): 6028-33, 2006 Dec 01.
Artículo en Inglés | MEDLINE | ID: mdl-16978864

RESUMEN

A series of novel di and trisaccharide derivatives containing d-fructose moiety at the reducing end have been synthesized and evaluated for their antihyperlipidemic activity in hyperlipidemic hamster model. Among 11 glycosyl fructose derivatives five compounds showed potent antihyperlipidemic activity either by enhancing high-density lipoprotein (HDL) cholesterol concentration and/or lowering triglyceride (TG) level.


Asunto(s)
Fructosa/química , Fructosa/uso terapéutico , Hipolipemiantes/síntesis química , Hipolipemiantes/uso terapéutico , Animales , Conformación de Carbohidratos , Cricetinae , Fructosa/análogos & derivados , Fructosa/síntesis química , Glicosilación , Hiperlipidemias/sangre , Hiperlipidemias/tratamiento farmacológico , Hipolipemiantes/química , Relación Estructura-Actividad
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA